Health Insurance Innovations Sees Q4 Adj. EPS $2.30-$2.55 vs $2.39 Estimate, Sales $159M-$164M vs $161.5M Est.; FY19 Adj. EPS $4.10-$4.35 vs $4.14 Est., Sales $380M-$385M vs $382.4M Est.
Benzinga Newsdesk